secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000886163-23-000030
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ligand annual meeting elects 7 directors, ratifies auditor, approves say-on-pay
-------------------------------------------------------------------------------

- All seven director nominees elected; Jason M. Aryeh received 7,967,581 for vs 6,131,999 withheld.
- Ratification of Ernst & Young as auditor passed with 15,512,124 for, 347,261 against.
- Non-binding advisory vote on executive compensation approved: 12,379,762 for, 1,698,528 against.
- Stockholders chose every-year frequency for say-on-pay votes (13,490,718 for 1 year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000088616323000030/0000886163-23-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000088616323000030/lgnd-20230609.htm
  HTML page:      https://secwatch.observer/filing/0000886163-23-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer